BC
REPL icon

Boxer Capital’s Replimune Group REPL Stock Holding History

Boxer Capital’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,536,341
Closed -$16.8M – 44
2024
Q3 		$16.8M Hold
1,536,341
– – 0.83% 35
2024
Q2 		$13.8M Buy
+1,536,341
New +$10.7M 0.73% 36

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Boxer Capital's REPL Position: Q4 2024 in Review

Boxer Capital sold out of Replimune Group (REPL) in Q4 2024, closing a stake of 1,536,341 shares — an estimated $16.8M sold.

Boxer Capital first reported a position in REPL in Q2 2024 and held it in 2 quarters. The position peaked at $16.8M in Q3 2024. 157 funds tracked by Wall St. Rank hold REPL as of Q4 2024.

  • Boxer Capital reported no remaining Replimune Group position as of Q4 2024 after selling out during the quarter.
  • Boxer Capital sold 1,536,341 Replimune Group shares in Q4 2024, an estimated $16.8M.
  • Boxer Capital first reported a position in Replimune Group in Q2 2024 and held it in 2 quarters.
  • Boxer Capital's Replimune Group position peaked at $16.8M in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Replimune Group as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.